X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.01
Delayed Data
As of May 29
 -0.043 / -2.09%
Today’s Change
1.55
Today|||52-Week Range
5.00
+1.52%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$24.4M

Company Description

XTL Biopharmaceuticals Ltd. is engaged in the acquisition, development, and commercialization of proprietary and pharmaceutical products. It also develops therapeutics such as erythropoietin program, SAM-101, and diversity oriented synthesis program. These medical products are created for the treatment of multiple myeloma, schizophrenia, and hepatitis C. The company was founded on March 9, 1993 and is headquartered in Herzliya, Israel.

Contact Information

XTL Biopharmaceuticals Ltd.
Herzliya Business Park
Herzliya -- 46766
P:(729) 955-7080
Investor Relations:

Employees

Shareholders

Other institutional10.33%
Mutual fund holders0.23%
Individual stakeholders--

Top Executives

Joshua LevineChief Executive Officer
David KestenbaumChief Financial Officer
Moshe MittelmanMedical Director
Daniel H. ShapiraInternal Auditor
Navon ShalomController

To view my watchlist

Not a member yet?

Sign up now for a free account